Sumitomo Life Sets Symetra Loose on a US Deal Hunt With Up to ¥1 Trillion to Invest as Japan's Insurers Keep Buying American

Sumitomo Life, one of Japan's biggest life insurers, is preparing to spend heavily on overseas growth, and it wants its American subsidiary Symetra to find the deals. According to a report by Stephen Owens in Insurance Business on October 16, 2026, the Osaka-based group has set aside up to ¥1 trillion, about $6.3 billion, for investment under a business plan that runs through March 2029. President Yukinori Takada told Bloomberg News that the United States and Southeast Asia are the target regions, and Singapore's Income Insurance was named as a possible Asian target.

Symetra, which is headquartered in Bellevue, Washington, will lead the search in the US for businesses that complement what it already does. Takada said Sumitomo Life will not pursue overseas growth at any price. Insurance Business describes the aim as acquisitions that "fit alongside, not on top of" existing operations, which suggests a preference for adding capabilities or distribution rather than duplicating them.

Symetra's recent activity offers a clue to the kind of deals it may seek. In October 2025 it closed a reinsurance transaction to take over the life and disability book of Dearborn Group from Health Care Service Corporation (HCSC), together with a multiyear agreement to sell group products to HCSC's healthcare customers. The deal lifted Symetra's life and disability business to about $1.1 billion in annualized premium and added 2.5 million covered lives. Migration of Dearborn policies onto Symetra contracts is still under way. A deal built around reinsurance and a distribution agreement, rather than a full company purchase, is a template that may be repeated.

Sumitomo Life has owned Symetra since February 2016, when it completed a takeover worth roughly $3.8 billion that took the company private from the New York Stock Exchange. Symetra kept its brand, management and Seattle-area headquarters. With consolidated total assets of about ¥51.6 trillion, or $322.6 billion, at the end of March, Sumitomo Life ranks fifth among Japan's life insurers, behind Nippon Life, Daiichi, Meiji Yasuda and Japan Post Insurance.

The strategy fits a broader pattern. Japanese life insurers have been among the most active foreign buyers of American insurance businesses. Meiji Yasuda bought StanCorp Financial, the parent of The Standard, in 2016 and completed a $2.3 billion purchase of Legal & General America in February 2026, adding Banner Life and a share of the pension risk transfer business. Nippon Life paid $3.8 billion for a 20% stake in Corebridge Financial in 2024, later completed its acquisition of Resolution Life and folded Resolution's US, UK and Bermuda operations into a new division, and nominates a director to Corebridge's board. Dai-ichi Life, now called Daiichi Life Group, has owned Protective Life of Birmingham, Alabama, since 2015.

Why are Japanese insurers looking abroad? The article does not spell out the motives, but they are widely understood. Japan's population is shrinking and ageing, which limits growth in domestic life insurance. The United States is the world's largest life and annuity market, with strong demand for retirement products and a large pool of assets, and has a long record of open acquisitions by foreign insurers. Buying an established American business gives a Japanese insurer diversification and access to a different growth cycle. These points are context rather than statements from the Insurance Business report.

Competition for deals is stiff. The report notes that Allianz beat Sumitomo Life to HSBC's Singapore life business earlier in 2026. Asia and the US are both busy markets for insurance acquisitions, with private equity, other insurers and sovereign investors all competing. PwC's recent review of US insurance mergers found that megadeals drove most of the deal value in the six months to May 2026 and that demand for life and annuity platforms remains strong although sponsors are more selective.

What would a Symetra-led acquisition look like in practice? It could be a block of life or disability policies, a group benefits business, a distribution partner or a specialist administrator. The source does not name any target or give a timetable, and Takada's comments were general. No deal has been announced. The ¥1 trillion figure is an upper limit for investment across the plan's regions and purposes, not a budget dedicated to a single purchase.

For American customers, such deals normally do not change their policy terms, since existing contracts transfer with the business and remain regulated by state insurance departments. For the industry, more Japanese ownership brings long-term capital that is comfortable holding policies for decades, but it also ties American insurers more closely to Japanese corporate decisions and to exchange-rate and interest-rate movements in Japan.

For investors and policymakers, the key questions will be how disciplined Sumitomo Life is on price, as it says, and how it balances the US against Southeast Asia, where it has already lost one bidding contest. Symetra's integration of the Dearborn book will also be an early test of its ability to digest larger transactions.